207 related articles for article (PubMed ID: 6997425)
1. Macrophages elicited with heat-killed bacillus Calomette-Guérin protect C57BL/6J mice against a syngeneic melanoma.
Freedman VH; Calvelli TA; Silagi S; Silverstein SC
J Exp Med; 1980 Sep; 152(3):657-73. PubMed ID: 6997425
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte subpopulations elicited by a nontumorigenic variant of B16 melanoma: their role in direct rejection of the melanoma and in prevention of tumorigenesis in Winn assays.
Calvelli TA; Freedman VH; Silverstein SC; Silagi S
J Exp Med; 1982 Dec; 156(6):1723-38. PubMed ID: 6983560
[TBL] [Abstract][Full Text] [Related]
3. Introduction of 65 kDa antigen of Mycobacterium tuberculosis to cancer cells enhances anti-tumor effect of BCG therapy.
Hara I; Sato N; Miyake H; Muramaki M; Hikosaka S; Kamidono S
Microbiol Immunol; 2004; 48(4):289-95. PubMed ID: 15107539
[TBL] [Abstract][Full Text] [Related]
4. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
5. In vitro cytotoxicity of peritoneal macrophages activated with Mycobacterium smegmatis.
Yamamoto S; Tokunaga T
Microbiol Immunol; 1978; 22(1):27-40. PubMed ID: 661626
[TBL] [Abstract][Full Text] [Related]
6. Bacillus Calmette-Guérin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling.
Borges VM; Marinho FV; Caldeira CVA; de Queiroz NMGP; Oliveira SC
Front Immunol; 2024; 15():1380069. PubMed ID: 38835781
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
[TBL] [Abstract][Full Text] [Related]
8. Rejection of sarcoma cells at the site of an inflammatory reaction: macrophages are not the only effector cells.
Parr IB; Wheeler LE; Alexander P
Cancer Lett; 1975 Sep; 1(1):49-53. PubMed ID: 797442
[TBL] [Abstract][Full Text] [Related]
9. Enhancing effect of coenzyme, Q10 on immunorestoration with Mycobacterium bovis BCG in tumor-bearing mice.
Kawase I; Niitani H; Saijo N; Sasaki H; Morita T
Gan; 1978 Aug; 69(4):493-7. PubMed ID: 101414
[TBL] [Abstract][Full Text] [Related]
10. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
[TBL] [Abstract][Full Text] [Related]
11. Destruction of experimental malignant melanoma by mediators of cellular immunity.
Youdim S
Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanoma: specific immunity induced by bacillus Calmette-Guérin in BALB-c mice.
Faraci RP; Schour L
Science; 1974 Jul; 185(4145):68-9. PubMed ID: 4599426
[TBL] [Abstract][Full Text] [Related]
13. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
Germain RN; Williams RM; Benacerraf B
J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
[TBL] [Abstract][Full Text] [Related]
14. Bacillus Calmette-Guérin-activated murine macrophages kill syngeneic melanoma cells under strict anaerobic conditions.
Freedman VH; Gorrell TE; Nathan CF; Copeland CS; Silverstein SC
J Exp Med; 1984 Jul; 160(1):94-107. PubMed ID: 6736873
[TBL] [Abstract][Full Text] [Related]
15. Studies on the antibody-dependent cell-mediated cytotoxicity (ADCC) of thioglycollate-stimulated and BCG-activated peritoneal macrophages.
Koren HS; Anderson SJ; Adams DO
Cell Immunol; 1981 Jan; 57(1):51-61. PubMed ID: 7011574
[No Abstract] [Full Text] [Related]
16. Reduced tumorigenicity of B16-F10 mouse melanoma cells transfected with mycobacterial antigen 85A.
Tarrant JP; Walsh MJ; Blanchard MC; Lee TD; Hoskin DW; Giacomantonio CA
Int J Oncol; 2004 Dec; 25(6):1693-9. PubMed ID: 15547707
[TBL] [Abstract][Full Text] [Related]
17. Catalytically inactive cyclooxygenase 2 and absence of prostaglandin E2 biosynthesis in murine peritoneal macrophages following in vivo phagocytosis of heat-killed Mycobacterium bovis bacillus Calmette-Guérin.
Yamashita M; Shinohara T; Tsuji S; Myrvik QN; Nishiyama A; Henriksen RA; Shibata Y
J Immunol; 2007 Nov; 179(10):7072-8. PubMed ID: 17982098
[TBL] [Abstract][Full Text] [Related]
18. Supernatants from ultraviolet-irradiated keratinocytes decrease the resistance and delayed-type hypersensitivity response to Mycobacterium bovis bacillus Calmette-Guerin in mice and impair the phagocytic ability of macrophages.
Jeevan A; Ullrich SE; Dizon VV; Kripke ML
Photodermatol Photoimmunol Photomed; 1991 Dec; 8(6):255-63. PubMed ID: 1823151
[TBL] [Abstract][Full Text] [Related]
19. Surface properties of bacillus Calmette-Guérin-activated mouse macrophages. Reduced expression of mannose-specific endocytosis, Fc receptors, and antigen F4/80 accompanies induction of Ia.
Ezekowitz RA; Austyn J; Stahl PD; Gordon S
J Exp Med; 1981 Jul; 154(1):60-76. PubMed ID: 7019381
[TBL] [Abstract][Full Text] [Related]
20. The effects of tumor facilitating factor of B16 melanoma on the macrophage.
Kalish R; Brody NI
J Invest Dermatol; 1983 Mar; 80(3):162-7. PubMed ID: 6827126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
